Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00819611
Other study ID # WM01022009
Secondary ID RN000142
Status Completed
Phase Phase 4
First received January 8, 2009
Last updated January 9, 2014
Start date June 2009
Est. completion date December 2013

Study information

Verified date January 2014
Source Radboud University
Contact n/a
Is FDA regulated No
Health authority Netherlands: The Central Committee on Research Involving Human Subjects (CCMO)
Study type Interventional

Clinical Trial Summary

The purpose of this study is to investigate whether working memory training improves behavioral symptoms, neurocognitive performance, and neural functioning in young children with ADHD.


Recruitment information / eligibility

Status Completed
Enrollment 51
Est. completion date December 2013
Est. primary completion date May 2013
Accepts healthy volunteers No
Gender Both
Age group 54 Months to 88 Months
Eligibility Inclusion Criteria:

- Age between 4 years/6 months and 7 years/4 months

- Diagnosis ADHD, classified by the DSM-IV (Diagnostic and Statistical Manual of Mental Disorders, 2000)

- A full scale IQ >= 80

- Psychopharmaca- naïve or -free

- Access to a PC with Windows Vista or Windows XP with internet connection and speakers at home

Exclusion Criteria:

- Currently intensive (i.e. weekly) individual or group psychotherapy

- Regular use of medication

- Diagnosis of one or more of the following comorbid psychiatric disorders: Major depression, Bipolar disorder, Psychotic disorder, Chronically motor tic disorder or Gilles de la Tourette, Conduct disorder, any other autism spectrum disorder except for Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS), Eating disorders, Anxiety disorders

- Neurological disorders (e.g. epilepsy) currently or in the past

- Cardiovascular disease currently or in the past

- Serious motor or perceptual handicap

- Participation in another clinical trial simultaneously

- Educational level and/ or socio-economic situation that makes it unlikely for the family to fulfil this study

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms

  • Attention Deficit Disorder With Hyperactivity
  • Hyperkinesis

Intervention

Behavioral:
Cogmed Working memory training
15 minutes of working memory training, 5 days a week for a period of 5 weeks
Control version of Cogmed working memory training
15 minutes of 'sham' working memory training, 5 days a week for a period of 5 weeks

Locations

Country Name City State
Netherlands Karakter University Centre for Child and Adolescent Psychiatry Nijmegen Nijmegen

Sponsors (2)

Lead Sponsor Collaborator
Radboud University Netherlands Organisation for Scientific Research

Country where clinical trial is conducted

Netherlands, 

References & Publications (1)

Klingberg T, Fernell E, Olesen PJ, Johnson M, Gustafsson P, Dahlström K, Gillberg CG, Forssberg H, Westerberg H. Computerized training of working memory in children with ADHD--a randomized, controlled trial. J Am Acad Child Adolesc Psychiatry. 2005 Feb;44(2):177-86. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary ADHD criteria according to the DSM-IV-TR rated by the investigator 7 weeks No
Secondary Neurocognitive performance and electrocortical activity 7 weeks No
See also
  Status Clinical Trial Phase
Completed NCT00202605 - Safety and Efficacy of SPD465 in Adults With ADHD Phase 2
Not yet recruiting NCT02677519 - A 12-Month Open Label Safety Study of Aptensio XR® in Children Ages 4-5 Years Diagnosed With ADHD Phase 4
Completed NCT02730572 - Concerta (Methylphenidate) -To-Generic Switch Study N/A
Completed NCT01681082 - Psychological Effects of Tai Chi Training N/A
Active, not recruiting NCT01330693 - Cortical Excitability: Phenotype and Biomarker in Attention-deficit, Hyperactivity Disorder (ADHD) Therapy Phase 3
Completed NCT00830700 - Children's Attention Deficit Disorder With Hyperactivity (ADHD) Telemental Health Treatment Study N/A
Completed NCT00626236 - Phase 2a Study of Safety and Tolerability of SPN-810 in Children With ADHD and Persistent Serious Conduct Problems Phase 2
Completed NCT01012622 - An Efficacy and Safety Study of Osmotic Release Oral System (OROS) Methylphenidate in Participants With Attention Deficit Hyperactivity Disorder (ADHD) Phase 4
Completed NCT00598182 - Adherence and Long-term Effect of OROS Methylphenidate (CONCERTA): A Follow-up Study N/A
Completed NCT00381407 - Organizational Skills Training for Children With Attention Deficit Hyperactivity Disorder N/A
Completed NCT00178503 - Methylphenidate for Attention Deficit Hyperactivity Disorder and Autism in Children Phase 2/Phase 3
Completed NCT00247572 - Safety, Tolerability and Abuse Liability Study of Intravenous NRP104 in Adults With Stimulant Abuse Histories Phase 2
Completed NCT00557011 - NRP104, Adderall XR or Placebo in Children Aged 6-12 Years With ADHD Phase 2
Completed NCT00118911 - Cognitive Behavioral Therapy for Treatment of Adult Attention Deficit Hyperactivity Disorder N/A
Completed NCT00218322 - Effectiveness of ATMX in Treating Adolescents With ADHD and SUD Phase 4
Completed NCT00071656 - Psychosocial Treatment for Attention Deficit Hyperactivity Disorder (ADHD) Type I N/A
Active, not recruiting NCT00057668 - Preventing Behavior Problems in Children With ADHD Phase 2
Completed NCT00050622 - Behavioral Treatment, Drug Treatment, and Combined Treatment for Attention Deficit Hyperactivity Disorder (ADHD) N/A
Completed NCT00050050 - Cognitive Behavioral Therapy for Adult Attention Deficit Hyperactivity Disorder Phase 1
Completed NCT00031395 - Clonidine in Attention Deficit Hyperactivity Disorder (ADHD) in Children Phase 3